Lilly will sell a version of its popular insulin at half the price, but will this appease critics?

Lilly will sell a version of its popular insulin at half the price, but will this appease critics?

Source: 
Stat
snippet: 

As drug makers come under increasing pressure to lower prices, Eli Lilly (LLY) is trying to thread a needle by introducing a new version of insulin at half the list price.